Home › enrollment
 

Keywords :   


Tag: enrollment

Funding cuts have dropped California community college enrollment to 20-year low

2013-03-28 19:14:00| American School & University

Report says if enrollment rates had remained steady, 600,000 more students would be enrolled in the state's community colleges.Schoolhouse Beat read more

Tags: community low college california

 

Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes

2013-03-28 09:57:29| dairynetwork Home Page

Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.

Tags: the of treatment trial

 
 

Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes

2013-03-28 09:57:29| dairynetwork News Articles

Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.

Tags: the of treatment trial

 

Long-term enrollment decline for Detroit-area Catholic schools

2013-02-01 16:31:00| American School & University

Since Baby Boom peak in mid-60s, student numbers have dropped precipitously. Schoolhouse Beat read more

Tags: schools decline catholic enrollment

 

RXi Pharmaceuticals Announces Completion of Enrollment in Second Phase 1 Trial for RXI-109 Program

2013-01-31 09:52:58| Biotech - Topix.net

RXi Pharmaceuticals Corporation , a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that its second Phase 1 study with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and ... (more)

Tags: program trial phase completion

 

Sites : [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »